Clinical Decision Support Tool

GLP-1 Facial Treatment
Protocol Generator

Generate evidence-based treatment protocols for GLP-1 agonist-induced facial volume loss ("Ozempic Face") using Sculptra and Restylane. Based on Galderma expert consensus guidelines (Nikolis et al., 2026).

Patient Assessment

Select patient parameters to generate a customised treatment protocol.

1Patient Gender

FemaleStandard Protocol

MaleModified Zones

2Age Group

3Weight Loss Category

4Weight Loss Speed

Rapid weight loss (< 15 weeks) is associated with accelerated facial aging and requires more aggressive volume restoration.

5Clinical Signs

Select observed clinical signs to generate tailored HA filler recommendations.

Temporal Hollowing

Midface Volume Loss

Jawline Laxity / Jowls

Skin Quality / Texture Issues

Deep Nasolabial Folds

Marionette Lines

Tear Trough Deformity

Lip Volume Loss

Clinic Configuration

Reconstitution Volume

Total volume per vial determines the final PLLA concentration.

Reference: Nikolis et al. (2026) utilized a 9mL reconstitution (8mL SWFI + 1mL Lidocaine).

GLP-1 Facial Treatment Protocol Generator

GLP-1 Facial Treatment
Protocol Generator